DWAS Among Small Cap ETFs
End-of-day Nov 13, 2026 · 97 Small cap ETFs by YTD
Loading…
Getting the latest data.
InvescoUS Stock StylesSmall Cap#511 of 694 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | +2.0% | −0.1% | −13.6% | +7.4% | +11.6% | +47.9% | +8.0% | +339.4% |
| Peer average | 0.0% | +1.8% | +1.5% | −5.2% | +16.2% | +17.9% | +63.3% | +29.4% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$19 of every $1,000 in DWAS is Replimune
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REPLReplimune Group | Healthcare | 1.93% | $193.02 | 352K | $7.7M |
| 2 | AMRXAmneal Pharmaceuticals | Healthcare | 1.73% | $173.08 | 316K | $6.9M |
| 3 | ANROAlto Neuroscience | Healthcare | 1.72% | $172.41 | 220K | $6.8M |
| 4 | ORKAOruka Therapeutics | Healthcare | 1.62% | $162.10 | 60K | $6.4M |
| 5 | AAMIAcadian Asset Management | Financial Services | 1.48% | $148.27 | 61K | $5.9M |
| 6 | VCTRVictory Capital | Financial Services | 1.41% | $141.47 | 45K | $5.6M |
| 7 | ADPTAdaptive Biotechnologies | Healthcare | 1.40% | $139.60 | 185K | $5.5M |
| 8 | FEIMFrequency Electronics | Technology | 1.29% | $128.52 | 75K | $5.1M |
| 9 | XMTRXometry | Industrials | 1.24% | $123.97 | 40K | $4.9M |
| 10 | AEHRAEHR Test Systems | Technology | 1.09% | $109.04 | 66K | $4.3M |
| 11 | INBXInhibrx Biosciences | Healthcare | 1.03% | $102.87 | 45K | $4.1M |
| 12 | NBNNortheast Bank | Financial Services | 1.01% | $100.80 | 31K | $4.0M |
| 13 | RLAYRelay Therapeutics | Healthcare | 1.00% | $99.84 | 201K | $4.0M |
| 14 | PRMPerimeter Group | Basic Materials | 0.97% | $96.75 | 125K | $3.8M |
| 15 | DXPEDXP Enterprises /TX | Industrials | 0.94% | $93.55 | 24K | $3.7M |
of the $580B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REPL | Replimune Group | 1.93% |
| 2 | AMRX | Amneal Pharmaceuticals | 1.73% |
| 3 | ANRO | Alto Neuroscience | 1.72% |
| 4 | ORKA | Oruka Therapeutics | 1.62% |
| 5 | AAMI | Acadian Asset Management | 1.48% |
| 6 | VCTR | Victory Capital | 1.41% |
| 7 | ADPT | Adaptive Biotechnologies | 1.40% |
| 8 | FEIM | Frequency Electronics | 1.29% |
| 9 | XMTR | Xometry | 1.24% |
| 10 | AEHR | AEHR Test Systems | 1.09% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0354 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0053 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0100 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0524 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0731 |
| Sep 23, 2024 | Sep 27, 2024 | $0.51 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0821 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0488 |
| Dec 18, 2023 | Dec 22, 2023 | $0.83 |
| Sep 18, 2023 | Sep 22, 2023 | $0.12 |
| Jun 20, 2023 | Jun 23, 2023 | $0.18 |
| Mar 20, 2023 | Mar 24, 2023 | $0.0547 |